WHITEWATER REGION (Cobden) — GlassHouse Botanics Inc. (GlassHouse) is thrilled to announce that it has received its Cultivation and Processing License from Health Canada. After months of intensive research, planning and construction this marks a significant milestone in their journey to becoming a global player in the medicinal cannabis industry.
With the completion of the first phase of construction, co-founders Dan Tauvette and Jeff Black, along with its management and cultivation team are extremely excited to begin cultivation of medicinal cannabis in their state-of-the- art, 43,000 square foot facility.
Once fully built out, the GlassHouse facility will be comprised of 520,000 square feet of greenhouse and headhouse with a production capacity of over 60,000 kg annually.
Significant progress is also being made globally as GlassHouse continues to focus on the largest medicinal cannabis market in the world – Europe. GlassHouse Botanics
International Limited set up operations in Malta over six months ago to fulfill its long-term business plan of obtain- ing a cannabis license in the country. The license will allow the company to carryout R&D, extraction and processing of medicinal cannabis in a Malta EUGMP certified facility for sales in the European market.
GlassHouse Botanics Inc. is a privately-held Canadian corporation in the business of cultivation and processing of pharmaceutical-grade medicinal Cannabis flower and derivatives.
